Variant‐specific effects of GBA1 mutations on dopaminergic neuron proteostasis
Journal of Neurochemistry · 2024
DOI: 10.1111/jnc.16114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, 2024. Verfasst von G Onal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Anatomy and Genetics, Kavli Institute for NanoScience Discovery, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Glucosylceramidase, Dopaminergic Neurons, Mutation, Proteostasis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hacettepe University Scientific Research Projects Coordination Unit, Scientific and Technological Research Council of Turkey (TÜBİTAK), Medical Research Council (MRC) Career Development Award.
Abstract (Originalsprache)
Glucocerebrosidase 1 ( GBA1 ) mutations are the most important genetic risk factors for Parkinson's disease (PD). Clinically, mild (e.g., p.N370S) and severe (e.g., p.L444P and p.D409H) GBA1 mutations have different PD phenotypes, with differences in age at disease onset, progression, and the severity of motor and non‐motor symptoms. We hypothesize that GBA1 mutations cause the accumulation of α‐synuclein by affecting the cross‐talk between cellular protein degradation mechanisms, leading to neurodegeneration. Accordingly, we tested whether mild and severe GBA1 mutations differentially affect the degradation of α‐synuclein via the ubiquitin–proteasome system (UPS), chaperone‐mediated autophagy (CMA), and macroautophagy and differentially cause accumulation and/or release of α‐synuclein. Our results demonstrate that endoplasmic reticulum (ER) stress and total ubiquitination rates were significantly increased in cells with severe GBA1 mutations. CMA was found to be defective in induced pluripotent stem cell (iPSC)‐derived dopaminergic neurons with mild GBA1 mutations, but not in those with severe GBA1 mutations. When examining macroautophagy, we observed reduced formation of autophagosomes in cells with the N370S and D409H GBA1 mutations and impairments in autophagosome–lysosome fusion in cells with the L444P GBA1 mutation. Accordingly, severe GBA1 mutations were found to trigger the accumulation and release of oligomeric α‐synuclein in iPSC‐derived dopaminergic neurons, primarily as a result of increased ER stress and defective macroautophagy, while mild GBA1 mutations affected CMA, which is mainly responsible for the degradation of the monomeric form of α‐synuclein. Overall, our findings provide new insight into the molecular basis of the clinical variability in PD associated with different GBA1 mutations. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Anatomy and Genetics, Kavli Institute for NanoScience Discovery, University of Oxford, Oxford, UK.
- Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
- Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
- National Nanotechnology Research Center, UNAM-Institute of Materials Science and Nanotechnology, Bilkent University, Ankara, Turkey.
- Translational Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
- Interdisciplinary Neuroscience Program, National Nanotechnology Research Center, UNAM-Institute of Materials Science and Nanotechnology, Bilkent University, Ankara, Turkey.
ORCID-Profile: I Boussaad, M M Salman
Förderung
- Hacettepe University Scientific Research Projects Coordination Unit
- Scientific and Technological Research Council of Turkey (TÜBİTAK)
- Medical Research Council (MRC) Career Development Award
- Biotechnology and Biological Sciences Research Council Pioneer Award
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
- Medical Research Council
Zitieren
APA
Onal, G., Yalçın-Çakmaklı, G., Özçelik, C. E., Boussaad, I., Şeker, U. Ö. Ş., Fernandes, H. J. R., Demir, H., Krüger, R., Elibol, B., Dökmeci, S., & Salman, M. M. (2024). Variant‐specific effects of GBA1 mutations on dopaminergic neuron proteostasis. Journal of Neurochemistry. https://doi.org/10.1111/jnc.16114
Vancouver
Onal G, Yalçın-Çakmaklı G, Özçelik CE, Boussaad I, Şeker UÖŞ, Fernandes HJR, et al. Variant‐specific effects of GBA1 mutations on dopaminergic neuron proteostasis. Journal of Neurochemistry. 2024. doi:10.1111/jnc.16114
BibTeX
@article{Onal2024,
author = {Onal, G and Yalçın-Çakmaklı, G and Özçelik, C E and Boussaad, I and Şeker, U Ö Ş and Fernandes, Hugo J R and Demir, H and Krüger, R and Elibol, B and Dökmeci, S and Salman, M M},
title = {Variant‐specific effects of GBA1 mutations on dopaminergic neuron proteostasis},
journal = {Journal of Neurochemistry},
year = {2024},
doi = {10.1111/jnc.16114}
}
EUVIMED